YY/T 1527-2017 PDF English
Price & Delivery
US$90.00 · In stock · Download in 9 secondsYY/T 1527-2017: α/β-Thalassemia gene typing detection kit
Delivery: 9 seconds. True-PDF full-copy in English & invoice will be downloaded + auto-delivered via email. See step-by-step procedure
Status: Valid
| Standard ID | USD | BUY PDF | Delivery | Standard Title (Description) | Status |
| YY/T 1527-2017 | 90 | Add to Cart | Auto, 9 seconds. | α/β-Thalassemia gene typing detection kit | Valid |
Click to Preview this PDF
YY/T 1527-2017: α/β-Thalassemia gene typing detection kit
---This is an excerpt. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.), auto-downloaded/delivered in 9 seconds, can be purchased online: https://www.ChineseStandard.net/PDF.aspx/YYT1527-2017YY NATIONAL PHARMACEUTICAL INDUSTRY STANDARD OF THE PEOPLE’S REPUBLIC OF CHINA ICS 11.100 C 44 α/β-Thalassemia Gene Typing Detection Kit Issued on: MARCH 28, 2017 Implemented on: APRIL 01, 2018 Issued by. China Food and Drug Administration
Table of Contents
Foreword ... 3 1 Scope ... 4 2 Normative References ... 4 3 Terms and Definitions ... 4 4 Designation, Classification and Composition ... 5 5 Requirements ... 5 6 Test Methods ... 6 7 Mark, Label and Use Instructions ... 8 8 Package, Transportation and Storage ... 8 Bibliography ... 9 α/β-Thalassemia Gene Typing Detection Kit1 Scope
This Standard specifies the terms and definitions, designation, classification and composition, requirements, test methods, mark, label and use instructions, package, transportation and storage of α/β-thalassemia gene typing detection kit (hereinafter referred to as “kit”). This Standard is applicable to the detection kit for detecting peripheral whole blood samples and pregnant amniotic fluid samples; the adopted technical methods include real-time PCR fluorescent method, PCR-reverse dot hybridization method, fluorescent PCR melting curve method, gene chip method, and gap PCR (gap-PCR) method, etc.2 Normative References
The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) are applicable to this document. GB/T 191-2008 Packaging – Pictorial Marking for Handling of Goods GB/T 29791.2 In Vitro Diagnostic Medical Devices - Information Supplied by the Manufacturer (Labelling) - Part 2. In Vitro Diagnostic Reagents for Professional Use3 Terms and Definitions
The following terms and definitions are applicable to this document. 3.1 Thalassemia It is also known as maritime anemia. It is a group of hereditary small cell hypochromic hemolytic anemia; its common feature is that due to the defects in the globin gene, one or several synthesis of globin peptide chains in hemoglobin is reduced or cannot be synthesized; resulting in changes in the composition of hemoglobin; it is mostly manifested clinically as chronic progressive hemolytic anemia. detection range of the kit; both are negative. 5.4 Detection limit Test with a national reference product or a standardized enterprise reference product of no-more-than 25ng or 4000 copies of thalassemia genotype; the results are both positive; conform to the corresponding genotype. 5.5 Repeatability 5.5.1 Fluorescent PCR method. it shall conform to the provisions of the coefficient of variation (CV) of the Ct value of fluorescent PCR method shall not exceed 5.0%. 5.5.2 Fluorescent PCR melting curve method, gap PCR (gap-PCR) method. test with the reference product with the same repeatability; the results are the same. 5.5.3 Membrane hybridization or gene chip method. test with the reference product with the same repeatability; the array spots on the membrane strip or chip shall be colored; the test results shall be the same; and the color development shall be uniform. 5.6 Nucleic acid extraction efficiency Extract the minimum amount of peripheral whole blood, fetal amniotic fluid cells or simulated solution specified by the kit; the concentration of nucleic acid shall be no less than 10ng/µL. NOTE. if the final amount of nucleic acid cannot be determined, it can only be tested with a positive sample of thalassemia; both results are positive; and conform to the corresponding genotype. 5.7 Stability The manufacturer shall specify the period of the shelf life of product. Take the product for a certain period of time before the expiration of valid date; test the accuracy, specialty, detection limit, repeatability, nucleic acid extraction efficiency of the reagent; the results shall meet the requirements of 5.2, 5.3, 5.4, 5.5 and 5.6.6 Test Methods
6.1 Appearance Take visual examination with normal or corrected visual acuity under natural light, the results shall meet the requirements of 5.1. 6.2 Accuracy ......Source: Above contents are excerpted from the full-copy PDF -- translated/reviewed by: www.ChineseStandard.net / Wayne Zheng et al.
